Share Price and Basic Stock Data
Last Updated: October 18, 2025, 6:03 pm
| PEG Ratio | 0.48 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Narmada Agrobase Ltd operates in the animal and shrimp feed industry, with a current stock price of ₹25.4 and a market capitalization of ₹97.9 Cr. The company has shown fluctuating revenue trends over recent quarters. For instance, sales stood at ₹7.91 Cr in June 2022, peaked at ₹18.26 Cr in March 2023, but dipped to ₹7.95 Cr in June 2023 before rebounding to ₹11.41 Cr in September 2023. Annual sales have also varied, recording ₹49.48 Cr in March 2023 and marginally increasing to ₹49.74 Cr in March 2024. However, projections for March 2025 indicate a significant rise to ₹65.68 Cr. The company has a cash conversion cycle (CCC) of 260.66 days, which is relatively high compared to industry norms, indicating potential inefficiencies in inventory and receivables management. This trend highlights the need for improved operational strategies to enhance cash flow and overall performance.
Profitability and Efficiency Metrics
Narmada Agrobase reported an operating profit margin (OPM) of 11.91%, which reflects a robust performance compared to typical industry averages. The operating profit for the most recent quarter (June 2025) was ₹1.32 Cr, demonstrating a consistent recovery in profitability following a dip in earlier quarters. Net profit in March 2025 reached ₹4.09 Cr, resulting in an earnings per share (EPS) of ₹1.08. The return on equity (ROE) stood at 11.2%, while return on capital employed (ROCE) increased to 13.05%, indicating effective utilization of equity and capital. The interest coverage ratio (ICR) of 2.70x suggests that the company comfortably meets its interest obligations, though it is crucial to remain vigilant against rising debt levels. Overall, while profitability metrics are improving, the company must focus on maintaining efficiency to sustain these gains.
Balance Sheet Strength and Financial Ratios
The balance sheet of Narmada Agrobase reflects a total borrowing of ₹9.47 Cr against reserves of ₹17.93 Cr, indicating a relatively healthy reserve position compared to its debt levels. The debt-to-equity ratio stands at 0.57, which is moderate and suggests that the company is leveraging its equity effectively without overextending its debt. The current ratio of 2.24 and quick ratio of 1.33 demonstrate strong liquidity, enabling the company to meet short-term obligations adequately. Additionally, the book value per share increased to ₹12.47 in March 2024, illustrating a solid growth in net worth. However, the high cash conversion cycle raises concerns about operational efficiency, indicating that the company may need to optimize inventory management and receivables collection processes to enhance liquidity further.
Shareholding Pattern and Investor Confidence
Narmada Agrobase’s shareholding structure comprises 50.30% promoters, 8.96% from domestic institutional investors (DIIs), and 40.74% held by the public. The proportion of promoter holding has decreased from 66.47% in September 2022 to 50.30% by June 2025, which may raise concerns about long-term commitment. Conversely, the increase in public shareholding from 33.53% to 40.74% during the same period indicates growing investor interest. The number of shareholders surged from 159 in September 2022 to 11,531 by June 2025, reflecting a significant rise in retail participation and confidence in the company’s future. This shift in the shareholding pattern suggests a diversification of ownership, which could potentially stabilize the stock price in the long run, provided the company continues to perform well.
Outlook, Risks, and Final Insight
If margins sustain and the company can effectively manage its cash conversion cycle, Narmada Agrobase could see continued growth in revenues and profitability. However, the risks include the declining trend in promoter shareholding, which may affect management’s control and strategic direction. Additionally, the high cash conversion cycle could hinder liquidity if not addressed. While the financial ratios indicate a solid foundation, the company must remain vigilant about operational efficiencies and market conditions that could impact profitability. Overall, if the company capitalizes on its strengths, including robust profitability metrics and a healthy balance sheet, it can navigate the challenges ahead and unlock greater shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Narmada Agrobase Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Narmada Agrobase Ltd | 90.8 Cr. | 23.9 | 28.4/14.4 | 22.2 | 14.7 | 0.00 % | 13.0 % | 11.2 % | 10.0 |
| Godrej Agrovet Ltd | 12,645 Cr. | 657 | 876/645 | 27.8 | 124 | 1.67 % | 16.6 % | 17.7 % | 10.0 |
| Avanti Feeds Ltd | 9,354 Cr. | 687 | 965/542 | 16.2 | 206 | 1.31 % | 24.0 % | 19.5 % | 1.00 |
| Ajooni Biotech Ltd | 88.4 Cr. | 5.13 | 8.55/5.01 | 24.1 | 5.11 | 0.00 % | 6.91 % | 5.15 % | 2.00 |
| Industry Average | 10,999.50 Cr | 343.26 | 22.58 | 87.45 | 0.75% | 15.13% | 13.39% | 5.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.91 | 13.24 | 10.62 | 18.26 | 7.95 | 11.41 | 12.22 | 18.75 | 12.26 | 10.28 | 13.84 | 29.30 | 11.08 |
| Expenses | 7.52 | 12.61 | 10.06 | 17.81 | 7.50 | 10.94 | 11.77 | 17.60 | 10.68 | 8.21 | 12.50 | 28.71 | 9.76 |
| Operating Profit | 0.39 | 0.63 | 0.56 | 0.45 | 0.45 | 0.47 | 0.45 | 1.15 | 1.58 | 2.07 | 1.34 | 0.59 | 1.32 |
| OPM % | 4.93% | 4.76% | 5.27% | 2.46% | 5.66% | 4.12% | 3.68% | 6.13% | 12.89% | 20.14% | 9.68% | 2.01% | 11.91% |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.00 | 0.01 | 0.01 | 0.32 | 0.32 | 0.33 |
| Interest | 0.20 | 0.19 | 0.22 | 0.25 | 0.23 | 0.23 | 0.23 | 0.26 | 0.24 | 0.24 | 0.21 | 0.16 | 0.24 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
| Profit before tax | 0.12 | 0.37 | 0.27 | 0.13 | 0.16 | 0.20 | 0.17 | 0.82 | 1.29 | 1.78 | 1.39 | 0.69 | 1.36 |
| Tax % | 33.33% | 27.03% | 25.93% | 23.08% | 31.25% | 15.00% | 23.53% | 25.61% | 21.71% | 26.97% | 28.06% | -13.04% | 25.00% |
| Net Profit | 0.08 | 0.27 | 0.20 | 0.10 | 0.11 | 0.17 | 0.13 | 0.61 | 1.02 | 1.29 | 1.00 | 0.78 | 1.02 |
| EPS in Rs | 0.02 | 0.07 | 0.05 | 0.03 | 0.03 | 0.04 | 0.03 | 0.16 | 0.27 | 0.34 | 0.26 | 0.21 | 0.27 |
Last Updated: August 20, 2025, 6:25 am
Below is a detailed analysis of the quarterly data for Narmada Agrobase Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11.08 Cr.. The value appears to be declining and may need further review. It has decreased from 29.30 Cr. (Mar 2025) to 11.08 Cr., marking a decrease of 18.22 Cr..
- For Expenses, as of Jun 2025, the value is 9.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 28.71 Cr. (Mar 2025) to 9.76 Cr., marking a decrease of 18.95 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 1.32 Cr., marking an increase of 0.73 Cr..
- For OPM %, as of Jun 2025, the value is 11.91%. The value appears strong and on an upward trend. It has increased from 2.01% (Mar 2025) to 11.91%, marking an increase of 9.90%.
- For Other Income, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Jun 2025, the value is 0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Mar 2025) to 0.24 Cr., marking an increase of 0.08 Cr..
- For Depreciation, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.36 Cr.. The value appears strong and on an upward trend. It has increased from 0.69 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 0.67 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -13.04% (Mar 2025) to 25.00%, marking an increase of 38.04%.
- For Net Profit, as of Jun 2025, the value is 1.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.78 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.24 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.27. The value appears strong and on an upward trend. It has increased from 0.21 (Mar 2025) to 0.27, marking an increase of 0.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:47 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.97 | 30.53 | 34.45 | 37.00 | 47.50 | 61.46 | 58.14 | 34.61 | 49.48 | 49.74 | 64.68 | 64.50 |
| Expenses | 21.12 | 29.35 | 33.02 | 35.43 | 45.87 | 59.00 | 55.90 | 32.61 | 47.46 | 47.22 | 59.10 | 59.18 |
| Operating Profit | 0.85 | 1.18 | 1.43 | 1.57 | 1.63 | 2.46 | 2.24 | 2.00 | 2.02 | 2.52 | 5.58 | 5.32 |
| OPM % | 3.87% | 3.87% | 4.15% | 4.24% | 3.43% | 4.00% | 3.85% | 5.78% | 4.08% | 5.07% | 8.63% | 8.25% |
| Other Income | 0.02 | 0.02 | 0.02 | 0.07 | 0.28 | 0.03 | 0.04 | 0.06 | 0.05 | 0.07 | 0.66 | 0.98 |
| Interest | 0.43 | 0.70 | 0.75 | 0.82 | 0.70 | 1.03 | 0.85 | 0.82 | 0.86 | 0.96 | 0.84 | 0.85 |
| Depreciation | 0.27 | 0.27 | 0.30 | 0.28 | 0.54 | 0.40 | 0.42 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 |
| Profit before tax | 0.17 | 0.23 | 0.40 | 0.54 | 0.67 | 1.06 | 1.01 | 0.87 | 0.89 | 1.35 | 5.16 | 5.22 |
| Tax % | 17.65% | 21.74% | 25.00% | 25.93% | 25.37% | 25.47% | 32.67% | 31.03% | 26.97% | 24.44% | 20.74% | |
| Net Profit | 0.14 | 0.19 | 0.30 | 0.40 | 0.50 | 0.79 | 0.68 | 0.61 | 0.65 | 1.02 | 4.09 | 4.09 |
| EPS in Rs | 0.22 | 0.21 | 0.33 | 0.15 | 0.13 | 0.21 | 0.18 | 0.16 | 0.17 | 0.27 | 1.08 | 1.08 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 15.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 35.71% | 57.89% | 33.33% | 25.00% | 58.00% | -13.92% | -10.29% | 6.56% | 56.92% | 300.98% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.18% | -24.56% | -8.33% | 33.00% | -71.92% | 3.63% | 16.85% | 50.37% | 244.06% |
Narmada Agrobase Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 39% |
| 3 Years: | 89% |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 10% |
| 1 Year: | 31% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 11:30 am
Balance Sheet
Last Updated: June 16, 2025, 11:39 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.83 | 1.83 | 5.19 | 7.53 | 13.55 | 13.55 | 13.55 | 13.55 | 13.55 | 37.94 |
| Reserves | 0.11 | 0.30 | 0.64 | 0.42 | 6.04 | 0.71 | 1.39 | 1.68 | 2.33 | 3.35 | 17.93 |
| Borrowings | 6.71 | 7.93 | 10.22 | 7.39 | 9.13 | 8.44 | 8.69 | 9.72 | 10.07 | 9.68 | 9.47 |
| Other Liabilities | 0.89 | 0.67 | 0.98 | 1.44 | 0.88 | 1.57 | 3.29 | 1.55 | 1.37 | 1.38 | 1.12 |
| Total Liabilities | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 |
| Fixed Assets | 2.38 | 2.71 | 2.66 | 2.74 | 4.66 | 3.89 | 3.50 | 3.75 | 3.44 | 3.18 | 2.97 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Investments | 0.21 | 0.21 | 0.43 | 0.47 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6.37 | 7.81 | 10.58 | 11.23 | 18.31 | 20.38 | 23.42 | 22.75 | 23.88 | 24.78 | 63.47 |
| Total Assets | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 |
Below is a detailed analysis of the balance sheet data for Narmada Agrobase Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 37.94 Cr.. The value appears strong and on an upward trend. It has increased from 13.55 Cr. (Mar 2024) to 37.94 Cr., marking an increase of 24.39 Cr..
- For Reserves, as of Mar 2025, the value is 17.93 Cr.. The value appears strong and on an upward trend. It has increased from 3.35 Cr. (Mar 2024) to 17.93 Cr., marking an increase of 14.58 Cr..
- For Borrowings, as of Mar 2025, the value is 9.47 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 9.68 Cr. (Mar 2024) to 9.47 Cr., marking a decrease of 0.21 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1.12 Cr.. The value appears to be improving (decreasing). It has decreased from 1.38 Cr. (Mar 2024) to 1.12 Cr., marking a decrease of 0.26 Cr..
- For Total Liabilities, as of Mar 2025, the value is 66.46 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.96 Cr. (Mar 2024) to 66.46 Cr., marking an increase of 38.50 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2.97 Cr.. The value appears to be declining and may need further review. It has decreased from 3.18 Cr. (Mar 2024) to 2.97 Cr., marking a decrease of 0.21 Cr..
- For CWIP, as of Mar 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 0.02 Cr., marking an increase of 0.02 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 63.47 Cr.. The value appears strong and on an upward trend. It has increased from 24.78 Cr. (Mar 2024) to 63.47 Cr., marking an increase of 38.69 Cr..
- For Total Assets, as of Mar 2025, the value is 66.46 Cr.. The value appears strong and on an upward trend. It has increased from 27.96 Cr. (Mar 2024) to 66.46 Cr., marking an increase of 38.50 Cr..
Notably, the Reserves (17.93 Cr.) exceed the Borrowings (9.47 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.86 | -6.75 | -8.79 | -5.82 | -7.50 | -5.98 | -6.45 | -7.72 | -8.05 | -7.16 | -3.89 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30.07 | 26.66 | 31.89 | 31.07 | 58.02 | 67.41 | 101.83 | 151.97 | 97.52 | 97.74 | 107.56 |
| Inventory Days | 73.60 | 54.43 | 70.88 | 75.62 | 70.33 | 37.81 | 28.83 | 77.66 | 75.95 | 84.67 | 154.49 |
| Days Payable | 10.54 | 6.97 | 8.63 | 11.98 | 3.54 | 4.02 | 15.92 | 10.03 | 7.25 | 6.35 | 1.38 |
| Cash Conversion Cycle | 93.13 | 74.11 | 94.14 | 94.71 | 124.80 | 101.19 | 114.74 | 219.59 | 166.22 | 176.06 | 260.66 |
| Working Capital Days | 21.27 | 25.70 | 26.81 | 25.35 | 59.01 | 53.09 | 64.10 | 104.62 | 87.34 | 94.00 | 194.58 |
| ROCE % | 10.26% | 10.11% | 10.59% | 7.68% | 9.21% | 8.20% | 6.96% | 6.88% | 8.79% | 13.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Diluted EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Cash EPS (Rs.) | 1.14 | 0.95 | 0.71 | 0.67 | 0.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Revenue From Operations / Share (Rs.) | 17.31 | 37.14 | 36.92 | 25.81 | 43.00 |
| PBDIT / Share (Rs.) | 1.64 | 1.91 | 1.53 | 1.46 | 1.68 |
| PBIT / Share (Rs.) | 1.58 | 1.71 | 1.29 | 1.19 | 1.37 |
| PBT / Share (Rs.) | 1.36 | 0.99 | 0.65 | 0.58 | 0.74 |
| Net Profit / Share (Rs.) | 1.08 | 0.75 | 0.48 | 0.40 | 0.55 |
| PBDIT Margin (%) | 9.49 | 5.14 | 4.13 | 5.64 | 3.91 |
| PBIT Margin (%) | 9.12 | 4.59 | 3.50 | 4.59 | 3.19 |
| PBT Margin (%) | 7.85 | 2.68 | 1.77 | 2.27 | 1.73 |
| Net Profit Margin (%) | 6.22 | 2.02 | 1.30 | 1.57 | 1.29 |
| Return on Networth / Equity (%) | 7.31 | 6.03 | 4.10 | 3.55 | 5.04 |
| Return on Capital Employeed (%) | 10.51 | 13.60 | 10.65 | 10.29 | 11.67 |
| Return On Assets (%) | 6.15 | 3.64 | 2.38 | 2.04 | 2.80 |
| Long Term Debt / Equity (X) | 0.02 | 0.01 | 0.03 | 0.00 | 0.05 |
| Total Debt / Equity (X) | 0.16 | 0.57 | 0.63 | 0.62 | 0.53 |
| Asset Turnover Ratio (%) | 1.39 | 1.82 | 1.85 | 1.30 | 2.29 |
| Current Ratio (X) | 6.21 | 2.24 | 2.14 | 1.97 | 1.96 |
| Quick Ratio (X) | 3.73 | 1.33 | 1.31 | 1.41 | 1.59 |
| Inventory Turnover Ratio (X) | 3.25 | 4.58 | 5.67 | 5.72 | 10.22 |
| Interest Coverage Ratio (X) | 7.44 | 2.70 | 2.40 | 2.43 | 2.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.88 | 2.06 | 1.76 | 1.68 | 1.88 |
| Enterprise Value (Cr.) | 56.46 | 36.45 | 40.59 | 36.04 | 21.25 |
| EV / Net Operating Revenue (X) | 0.85 | 0.72 | 0.81 | 1.03 | 0.36 |
| EV / EBITDA (X) | 9.05 | 14.08 | 19.62 | 18.26 | 9.31 |
| MarketCap / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| Price / BV (X) | 1.11 | 1.63 | 1.96 | 1.74 | 0.92 |
| Price / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| EarningsYield | 0.06 | 0.03 | 0.02 | 0.02 | 0.05 |
After reviewing the key financial ratios for Narmada Agrobase Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 3. It has increased from 0.95 (Mar 24) to 1.14, marking an increase of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 17.31. It has decreased from 37.14 (Mar 24) to 17.31, marking a decrease of 19.83.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 2. It has decreased from 1.91 (Mar 24) to 1.64, marking a decrease of 0.27.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.71 (Mar 24) to 1.58, marking a decrease of 0.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.36, marking an increase of 0.37.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has increased from 0.75 (Mar 24) to 1.08, marking an increase of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 9.49. This value is below the healthy minimum of 10. It has increased from 5.14 (Mar 24) to 9.49, marking an increase of 4.35.
- For PBIT Margin (%), as of Mar 25, the value is 9.12. This value is below the healthy minimum of 10. It has increased from 4.59 (Mar 24) to 9.12, marking an increase of 4.53.
- For PBT Margin (%), as of Mar 25, the value is 7.85. This value is below the healthy minimum of 10. It has increased from 2.68 (Mar 24) to 7.85, marking an increase of 5.17.
- For Net Profit Margin (%), as of Mar 25, the value is 6.22. This value is within the healthy range. It has increased from 2.02 (Mar 24) to 6.22, marking an increase of 4.20.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.31. This value is below the healthy minimum of 15. It has increased from 6.03 (Mar 24) to 7.31, marking an increase of 1.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 13.60 (Mar 24) to 10.51, marking a decrease of 3.09.
- For Return On Assets (%), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 6.15, marking an increase of 2.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.57 (Mar 24) to 0.16, marking a decrease of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.82 (Mar 24) to 1.39, marking a decrease of 0.43.
- For Current Ratio (X), as of Mar 25, the value is 6.21. This value exceeds the healthy maximum of 3. It has increased from 2.24 (Mar 24) to 6.21, marking an increase of 3.97.
- For Quick Ratio (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 3.73, marking an increase of 2.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 4. It has decreased from 4.58 (Mar 24) to 3.25, marking a decrease of 1.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.44. This value is within the healthy range. It has increased from 2.70 (Mar 24) to 7.44, marking an increase of 4.74.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.88. This value is within the healthy range. It has increased from 2.06 (Mar 24) to 5.88, marking an increase of 3.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 56.46. It has increased from 36.45 (Mar 24) to 56.46, marking an increase of 20.01.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.85, marking an increase of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 9.05. This value is within the healthy range. It has decreased from 14.08 (Mar 24) to 9.05, marking a decrease of 5.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For Price / BV (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.11, marking a decrease of 0.52.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narmada Agrobase Ltd:
- Net Profit Margin: 6.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.51% (Industry Average ROCE: 15.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.31% (Industry Average ROE: 13.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.2 (Industry average Stock P/E: 22.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Animal/Shrimp Feed | 613/P-1 IJ, Pura (Jethaji) Dhanpura Road, Mehsana Gujarat 384421 | infonarmadaagrobase@gmail.com http://www.narmadaagrobase.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Neerajkumar Sureshchandra Agrawal | Managing Director |
| Mr. Suresh Chandra Gupta | Whole Time Director |
| Ms. Pooja Aidasani | Ind. Non-Executive Director |
| Mr. Ganesh Bhavarlal Prajapati | Ind. Non-Executive Director |
| Mrs. Nidhi Dineshbhai Patel | Ind. Non-Executive Director |
| Mr. Gaurav Dineshkumar Agarwal | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Narmada Agrobase Ltd?
Narmada Agrobase Ltd's intrinsic value (as of 19 October 2025) is 29.82 which is 24.77% higher the current market price of 23.90, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 90.8 Cr. market cap, FY2025-2026 high/low of 28.4/14.4, reserves of ₹17.93 Cr, and liabilities of 66.46 Cr.
What is the Market Cap of Narmada Agrobase Ltd?
The Market Cap of Narmada Agrobase Ltd is 90.8 Cr..
What is the current Stock Price of Narmada Agrobase Ltd as on 19 October 2025?
The current stock price of Narmada Agrobase Ltd as on 19 October 2025 is 23.9.
What is the High / Low of Narmada Agrobase Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Narmada Agrobase Ltd stocks is 28.4/14.4.
What is the Stock P/E of Narmada Agrobase Ltd?
The Stock P/E of Narmada Agrobase Ltd is 22.2.
What is the Book Value of Narmada Agrobase Ltd?
The Book Value of Narmada Agrobase Ltd is 14.7.
What is the Dividend Yield of Narmada Agrobase Ltd?
The Dividend Yield of Narmada Agrobase Ltd is 0.00 %.
What is the ROCE of Narmada Agrobase Ltd?
The ROCE of Narmada Agrobase Ltd is 13.0 %.
What is the ROE of Narmada Agrobase Ltd?
The ROE of Narmada Agrobase Ltd is 11.2 %.
What is the Face Value of Narmada Agrobase Ltd?
The Face Value of Narmada Agrobase Ltd is 10.0.